Back to Search
MUNIR SHAHJAHAN, M.D., M.P.H., DR.PH
M.D., M.P.H., DR.PH
Anatomic Pathology & Clinical Pathology Physician
NPI: 1932344785Individual
Specialties, Licenses & Credentials
Hematology (Pathology) Physician
Pathology — Hematology
Code: 207ZH0000X
N5391(TX)
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
N5391(TX)
Research & Publications (20)
p38 mitogen-activated protein kinase has different degrees of activation in myeloproliferative disorders and myelodysplastic syndromes.
PMID 18794058·Am J Clin Pathol·2008
8-other
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.
PMID 17873123·Blood·2007
4-observational
Measuring the cost-effectiveness of a national health communication program in rural Bangladesh.
PMID 17148101·J Health Commun·2006
8-other
Seeking optimal means to address micronutrient deficiencies in food supplements: A case study from the Bangladesh Integrated Nutrition Project.
PMID 16599108·J Health Popul Nutr·2005
8-other
Effect of Solanum trilobatum on the antioxidant status during diethyl nitrosamine induced and phenobarbital promoted hepatocarcinogenesis in rat.
PMID 16188247·Chem Biol Interact·2005
7-preclinical
Protective effect of Indigofera oblongifolia in CCl4-induced hepatotoxicity.
PMID 16117622·J Med Food·2005
7-preclinical
Comorbidity indices in hematopoietic stem cell transplantation: a new report card.
PMID 15995717·Bone Marrow Transplant·2005
6-review
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia.
PMID 15937511·Bone Marrow Transplant·2005
8-other
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
PMID 15682071·Biol Blood Marrow Transplant·2005
8-other
Effect of Solanum trilobatum against carbon tetrachloride induced hepatic damage in albino rats.
PMID 15489557·Indian J Med Res·2004
4-observational
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation.
PMID 15090449·Blood·2004
8-other
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.
PMID 15073038·Blood·2004
8-other
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
PMID 15048141·Bone Marrow Transplant·2004
8-other
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters.
PMID 14726405·Blood·2004
8-other
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant.
PMID 14523458·Leukemia·2003
5-case
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.
PMID 12842990·Blood·2003
8-other
Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab.
PMID 12802922·Leuk Lymphoma·2003
5-case
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias.
PMID 12599231·Cancer·2003
3-trial
Nonablative stem cell transplantation for older patients with acute leukemias and myelodysplastic syndromes.
PMID 11799530·Semin Hematol·2002
6-review
Recommendations for water supply in arsenic mitigation: a case study from Bangladesh.
PMID 11114764·Public Health·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6565 FANNIN, M227
HOUSTON, TX 77030 - Phone
- (713) 441-3490
Quick Facts
- NPI
- 1932344785
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile